19 jul: Aktier/tendens: Nye marginale stigninger i vente
19 jul: Elektrolux slog alle analytikere af banen
19-07-2012 08:38:00

Co-Operative Buys Lloyds Branches, Leapfrogs into Big League

Relateret indhold

By Max Colchester and Jessica Hodgson

LONDON--Lloyds Banking Group PLC (LYG) Thursday said it will sell 632 of its retail branches to the Co-Operative Group Ltd (CPBB.LN), sealing a long-awaited deal that will transform the funerals-to-food group into the U.K.'s sixth-largest retail banking business with around 10% of the U.K. market.

Lloyds agreed to sell the branches for an initial consideration of GBP350 million, and up to an additional GBP400 million in present value--equivalent to around GBP800 million on a nominal basis subject to performance of the Co-Operative groups combined banking businesses over a 15-year period.

The figure is significantly below the estimated GBP1.5 billion that was reportedly offered when discussions began a year ago, reflecting the decline in the value of bank assets over the period.

Lloyds, which is roughly 40%-owned by the U.K. government, has to sell the branches on condition of receiving state aid when it was bailed out in 2008. But the sale, code-named Verde, has been dogged by regulatory issues related to the experience of the Co-Op's board and the amount of capital the group would have to hold if it boosted its banking business.

The sale of the branches is heralded by the British government as a way to boost competition in the U.K. banking sector. "This is another step towards creating a new banking system for Britain that gives real choice to customers and supports the economy," George Osborne, the U.K. Chancellor, said in a statement Thursday.

The Verde business has 632 branches and makes up 6% of the U.K. branch network and, when combined with the Co-Op's existing banking business, it makes up around 7% of U.K. current accounts.

The U.K.'s Independent Commission on Banking said a standalone bank needs to achieve 6% market share in order to be competitive.

"We believe the Co-Operative will be a good owner for our business, customers and colleagues, and the combined banking business will be a significant competitor on the high street with nearly 10% of today's U.K. branch network," Antonio Horta-Osorio, Lloyds' chief executive, said in a statement.

The Lloyds statement said the Co-Operative Group was expected to inject the branches with GBP1.5 billion of equity capital. The branches will have approximately GBP11 billion of risk-weighted assets on a standardised basis.

-Write to Max Colchester at max.colchester@wsj.com

(Ainsley Thomson in London contributed to this article.)

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 19, 2012 02:38 ET (06:38 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo mister tronen som tungeste aktie i C20 Cap

27-03-2017 09:40:18
Novo Nordisk har ikke længere den største indflydelse på udviklingen i det toneangivende danske aktieindeks, C20 Cap.Medicinalgiganten fra Bagsværd er faldet ned på andenpladsen i vægtningen i indekset trods en markedsværdi, der fortsat er klart den højeste blandt de børsnoterede danske selskaber.Danske Bank er den nye på topplaceringen med en vægt på 14,5 pct., mens Novo-aktien er faldet til 12,9..

Vind/Siemens: Hele vindindustrien vil få glæde af skatterabat

27-03-2017 06:34:14
Som led i et nyt vækstudspil vil Socialdemokratiet indføre en skatterabat på 130 procent for udgifter til forskning og udvikling.Sådan en aftale er efterspurgt blandt flere virksomheder i Danmark. En af dem er Siemens Windpower:- Det vil være en vigtig aftale, som hele vindindustrien vil få glæde af, da det er en industri, der er drevet af innovation og fornyelse.- Og sådan en aftale vil skabe de ..

Novo: EMA-udvalg anbefaler markedsføringstilladelse til Refixia - NY

24-03-2017 13:31:36
Udvalget for humanmedicinske lægemidler (CHMP) ved Det Europæiske Lægemiddelsagentur (EMA) har tildelt Novo Nordisks Refixia en positiv udtalelse og anbefaler en markedsføringstilladelse.Det skriver Novo Nordisk i en fondsbørsmeddelelse.CHMP anbefaler en markedsføringstilladelse til Refixia til unge og voksne med hæmofili B. Til grund for anbefalingen ligger resultater fra udviklingsprogrammet par..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo mister tronen som tungeste aktie i C20 Cap
2
Aktier/tendens: Trump-forlis kan sende aktier i minus
3
Vind/Siemens: Hele vindindustrien vil få glæde af skatterabat
4
Mærsk/Seaintel: Ratesucces 1. april er særligt vigtig
5
G4S/RBC: Løfter kursmålet med 13 pct.

Relaterede aktiekurser

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
27. marts 2017 12:45:33
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170324.2 - EUROWEB7 - 2017-03-27 12:45:33 - 2017-03-27 12:45:33 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x